NCT03542916View on ClinicalTrials.gov

Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2015

Conditions

Healthy Subjects

Interventions

DRUG

CJ-40001 60ug

CJ-40001 60ug SC, IV injection

DRUG

NESP 60ug

NESP 60ug SC, IV injection

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

Sponsors

Lead Sponsor

HK inno.N Corporation

All Listed Sponsors

lead

HK inno.N Corporation

INDUSTRY

NCT03542916 - Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers | Biotech Hunter | Biotech Hunter